Home › Lilly Forecasts Sales, Profit Drop on Rival Generic Drugs
 

Keywords :   


Lilly Forecasts Sales, Profit Drop on Rival Generic Drugs

2014-01-08 12:07:12| Biotech - Topix.net

Eli Lilly & Co., the leading U.S. maker of diabetes products, forecast a drop in 2014 profit and reduced its sales outlook because of generic competition to the its Cymbalta antidepressant and Evista drug for osteoporosis.

Tags: sales drop profit drugs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Mortgage costs 'biggest challenge' for homeowners
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Public Advisory Number 26A
05.07Atlantic Tropical Weather Outlook
05.07Eastern North Pacific Tropical Weather Outlook
05.07Samsung expects profits to jump by more than 1,400%
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 26
More »